Literature DB >> 34324657

Resistin deletion protects against heart failure injury by targeting DNA damage response.

Baoyin Zhao1, Rihab Bouchareb1, Djamel Lebeche1,2,3.   

Abstract

AIMS: Increased resistin (Retn) levels are associated with development of cardiovascular diseases. However, the role of Retn in heart failure (HF) is still unclear. Here we probed the functional and molecular mechanism underlying the beneficial effect of Retn deletion in HF. METHODS AND
RESULTS: Wild-type (WT) and adipose tissue-specific Retn-knockout (RKO) mice were subjected to transverse aortic constriction (TAC)-induced HF. Cardiac function and haemodynamic changes were measured by echocardiography and left ventricular catheterization. Adipose tissue Retn deletion attenuated while Retn cardiac-selective overexpression, via a recombinant adeno-associated virus-9 vector, exacerbated TAC-induced hypertrophy, cardiac dysfunction, and myocardial fibrosis in WT and RKO mice. Mechanistically, we showed that Gadd45α was significantly increased in RKO HF mice while cardiac overexpression of Retn led to its downregulation. miR148b-3p directly targets Gadd45α and inhibits its expression. Retn overexpression upregulated miR148b-3p expression and triggered DNA damage response (DDR) in RKO-HF mice. Inhibition of miR148b-3p in vivo normalized Gadd45α expression, decreased DDR, and reversed cardiac dysfunction and fibrosis. In vitro Retn overexpression in adult mouse cardiomyocytes activated miR148b-3p and reduced Gadd45α expression. Gadd45α overexpression in H9C2-cardiomyoblasts protected against hydrogen peroxide- and Retn-induced DDR.
CONCLUSION: These findings reveal that diminution in circulating Retn reduced myocardial fibrosis and apoptosis, and improved heart function in a mouse model of HF, at least in part, through attenuation of miR148b-3p and DDR. The results of this study indicate that controlling Retn levels may provide a potential therapeutic approach for treating pressure overload-induced HF. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DNA damage response; Gadd45α; Pressure overload heart failure; Resistin; miR148b-3p

Mesh:

Substances:

Year:  2022        PMID: 34324657      PMCID: PMC9239578          DOI: 10.1093/cvr/cvab234

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   13.081


  61 in total

Review 1.  Signaling pathways for cardiac hypertrophy and failure.

Authors:  J J Hunter; K R Chien
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats.

Authors:  Pál Pacher; Takahiro Nagayama; Partha Mukhopadhyay; Sándor Bátkai; David A Kass
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Association of plasma resistin levels with coronary heart disease in women.

Authors:  Tobias Pischon; Christoph M Bamberger; Jürgen Kratzsch; Birgit-Christiane Zyriax; Petra Algenstaedt; Heiner Boeing; Eberhard Windler
Journal:  Obes Res       Date:  2005-10

4.  The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications.

Authors:  Sudip Ghosh; Anil K Singh; Battu Aruna; Sangita Mukhopadhyay; Nasreen Z Ehtesham
Journal:  Gene       Date:  2003-02-13       Impact factor: 3.688

Review 5.  The emerging role of microRNAs in cardiac remodeling and heart failure.

Authors:  Vijay Divakaran; Douglas L Mann
Journal:  Circ Res       Date:  2008-11-07       Impact factor: 17.367

Review 6.  Growth arrest and DNA damage-45 alpha (GADD45alpha).

Authors:  A Rosemary Siafakas; Des R Richardson
Journal:  Int J Biochem Cell Biol       Date:  2008-08-05       Impact factor: 5.085

Review 7.  Gadd45 in stress signaling, cell cycle control, and apoptosis.

Authors:  Jesús M Salvador; Joshua D Brown-Clay; Albert J Fornace
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 8.  GammaH2AX and cancer.

Authors:  William M Bonner; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Olga A Sedelnikova; Stéphanie Solier; Yves Pommier
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

9.  Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis.

Authors:  Cerrone R Foster; Laura L Daniel; Christopher R Daniels; Suman Dalal; Mahipal Singh; Krishna Singh
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

10.  Gadd45α: a novel diabetes-associated gene potentially linking diabetic cardiomyopathy and baroreflex dysfunction.

Authors:  Ning Wang; Chao Yang; Fang Xie; Lihua Sun; Xiaolin Su; Ying Wang; Ran Wei; Rong Zhang; Xia Li; Baofeng Yang; Jing Ai
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.